Should managed care organizations pay for nicotine replacement therapy?
Westman
E C
EC
D003362:Cost-Benefit Analysis; D006801:Humans; D008329:Managed Care Programs / Q000191:economics*; D009538:Nicotine / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use; D016540:Smoking Cessation / Q000191:economics* / Q000379:methods; D014481:United States